Serum amyloid A: From fibril to function. Current status

References

• Benditt E P, Eriksen M, Hermodsen M A, Ericsson L H. The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences. FEBS Lett 1971; 19: 169–173
   PubMed Web of Science ®Google Scholar
• Uhlar C M, Whitehead A S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999; 265: 501–523
   PubMedGoogle Scholar
• Husby G, Marhaug G, Dowton B, Sletten K, Sipe J D. Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid: Int J Exp Clin Invest 1994; 1: 119–137
   Web of Science ®Google Scholar
• Sipe J. Committee Revised nomenclature for serum amyloid A (SAA). Amyloid: Int J Exp Clin Invest 1999; 6: 67–70
   PubMed Web of Science ®Google Scholar
• Li L, Liao W SL. An upstream repressor element that contributes to hepatocyte-specific expression of the rat serum amyloid Al gene. Biochem Bioph Res Comm 1999; 264: 395–403
   PubMedGoogle Scholar
• Jiang S-L, Samols D, Rzewnicki D, Macintyre S S, Greber I, Sipe J, Kushner I. Kinetic Modeling and Mathematical analysis indicate that acute phase gene expression in Hep3B cells is regulated by both transcriptional and post-transcriptional mechanisms. J Clin Invest 1995; 95: 1253–1261
   PubMed Web of Science ®Google Scholar
• Ray A, Ray B K. Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF, NF-kappa B, and C/EBP transcription factors. J Immunol 1999; 163: 2143–2150
   PubMed Web of Science ®Google Scholar
• Jensen L E, Whitehead A S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem 1998; 7334: 489–503
   Google Scholar
• Gonnerman W A, Elliott-Bryant R E, Carreras I, Sipe J D, Cathcart E S. Linkage of protection against amyloid fibril formation in the mouse to a single, autosomal dominant gene. J Exp Med 1995; 181: 2249–2252
   PubMed Web of Science ®Google Scholar
• Urieli-Shoval S, Linke R P, Matzner Y. Expression and function of serum amyloid A, a major acute phase protein, in normal and disease states. Current Opinion in Hematology 2000; 7: 64–69
   PubMed Web of Science ®Google Scholar
• Liang J-S, Schreiber B, Salmona M, Phillip G, Gonnerman W A, de Beer F C, Sipe J D. The amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and Hep G2 cells. J Lipid Res 1996; 37: 2109–2116
   PubMed Web of Science ®Google Scholar
• Ancsin J B, Kisilevsky R. The heparin heparan sulfate-binding site on apo serum amyloid A - Implications for the therapeutic intervention of amyloidosis. J Biol Chem 1999; 274: 7172–7181
   PubMed Web of Science ®Google Scholar
• Su S B, Gong W H, Gao J L, Shen W, Murphy P M, Oppenheim J J, Wang J M. A seven-transmembrane, G proteincoupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999; 189: 395–402
   PubMed Web of Science ®Google Scholar
• Schreiber B M, Veverbrants M, Fine R E, Blusztajn J K, Salmona M, Patel A, Sipe J D. Apolipoprotein serum amyloid A (SAA) down regulates smooth muscle cell lipid biosynthesis. Biochemical J 1999; 344: 7–13
   PubMedGoogle Scholar
• Banka C L, Yuan T, De Beer M C, Kindy M, Curtiss L K, De Beer F C. Serum Amyloid-A (SAA) - influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995; 36: 1058–1065
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Lindhorst E, Ancsin J B, Young D, Bagshaw W. Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: A hypothesis. Amyloid Int J Exp Clin Invest 1996; 3: 252–260
   Web of Science ®Google Scholar
• Lindhorst E, Young D, Bagshaw W, Hyland M, Kisilevsky R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997; 1339: 143–154
   PubMed Web of Science ®Google Scholar
• Liang J S, Sipe J D. Recombinant human serum amyloid A (apoSAA J binds cholesterol and modulates cholesterol flux. J Lipid Res 1995; 36: 37–46
   PubMed Web of Science ®Google Scholar
• Liang J S, Sloane J A, Wells J, Abraham C R, Fine R E, Sipe J D. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci Lett 1997; 225: 73–76
   PubMed Web of Science ®Google Scholar
• Chung T F, Sipe J D, McKee A, Fine R E, Schreiber B M, Liang J S, Johnson R J. Serum amyloid A in Alzheimer's disease brain is predominantly localized to myelin sheaths and axonal membrane. Amyloid: Int J Exp Clin Invest 2000, (In press)
   PubMedGoogle Scholar
• Elliott-Bryant R, Liang J S, Sipe J D, Cathcart E S. Degradation of serum amyloid A in amyloid-susceptible and amyloid-resistant mouse strains. Scand J Immunol 1996; 44: 222–228
   Google Scholar
• Liang J S, Stone P J, Sipe J D. Serum Amyloid-A (ApoSAAp) catabolism - dual cellular mechanisms and attenuation by lipids and lipoprotein. FASEB J 1995; 9: A1043
   PubMedGoogle Scholar
• Yamada T, Okuda Y, Itoh Y. The frequency of serum amyloid A2 alleles in the Japanese population. Amyloid: Int J Exp Clin Invest 1998; 5: 208–211
   PubMed Web of Science ®Google Scholar